Maternal arrhythmia management during pregnancy in patients with structural heart disease

Progress in Pediatric Cardiology

Volumn 19, Issue 1, 2004, Pages 71-82

  Lee, Joselyn C R ^a   Wetzel, Glenn ^a   Shannon, Kevin ^a  

^a MATTEL CHILDREN S HOSPITAL   (United States)

Author keywords

Congenital heart disease; Maternal arrhythmia; Pregnancy; Structural heart disease; Supraventricular arrhythmias; Supraventricular tachycardia

Indexed keywords

ADENOSINE; AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DILTIAZEM; ENCAINIDE; FLECAINIDE; GLYCOSIDE; LIDOCAINE; MEXILETINE; PHENYTOIN; PROCAINAMIDE; PROPRANOLOL DERIVATIVE; QUINIDINE; SOTALOL; TOCAINIDE; VERAPAMIL;

ABORTION; ACIDOSIS; ARTIFICIAL HEART PACEMAKER; BIRTH DEFECT; BRADYCARDIA; CARDIOTOXICITY; CARDIOVERSION; CATHETER ABLATION; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL TRIAL; CONGENITAL DISORDER; CONGENITAL MALFORMATION; DEFIBRILLATION; DRUG BLOOD LEVEL; FACE DYSMORPHIA; FETOTOXICITY; FETUS WASTAGE; GREAT VESSELS TRANSPOSITION; GROWTH RETARDATION; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART BLOCK; HEART DISEASE; HEART PACING; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPOGLYCEMIA; HYPOTENSION; HYPOTHYROIDISM; LOW BIRTH WEIGHT; META ANALYSIS; MICROCEPHALY; NEUROTOXICITY; PREGNANCY; PREMATURE LABOR; PREMATURITY; PRIORITY JOURNAL; RESPIRATION DEPRESSION; RESUSCITATION; REVIEW; RISK ASSESSMENT; SIDE EFFECT; SUPRAVENTRICULAR TACHYCARDIA; TACHYCARDIA; THROMBOCYTOPENIA; TORSADE DES POINTES; TRACHEA STENOSIS;

EID: 2342472003     PISSN: 10589813     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ppedcard.2003.09.002     Document Type: Article

References (84)

1. Blalock A., Taussig H. Landmark article May 19, 1945. The surgical treatment of malformations of the heart in which there is pulmonary stenosis or pulmonary atresia. J Am Med Assoc. 251:(16):Apr 27 1984;2123-2138
2. Fontan F., Baudet E. Surgical repair of tricuspid atresia. Thorax. 26:1971;24
3. Hamilton H.F.H. The cardiac output in normal pregnancy as determined by the Cournand right heart catheterization technique. J Obstet Gynaecol Br Emp. 56:1949;548-552
4. Roy B.S., Malkani P.K., Virik R., Bhatia M.L. Circulatory effects of pregnancy. Am J Obstet Gynecol. 96:1966;221-225
5. Lees M.M., Taylor S.H., Scott D.B., Kerr M.G. A study of cardiac output at rest throughout pregnancy. J Obstet Gynaecol Br Commonw. 74:1967;319-328
6. Rubler S., Prabodhkumar M.D., Pinto E.R. Cardiac size and performance during pregnancy estimated with echocardiography. Clin Obstet Gynecol. 40:1977;534-540
7. Katz R., Karliner J.S., Resnik R. Effects of a natural volume overload state (pregnancy) on left ventricular performance in normal human subjects. Circulation. 58:1978;434-441
8. Kerr M.G. Cardiovascular dynamics in pregnancy and labour. Br Med Bull. 24:1968;19-24
9. Joglar J.A., Page R.L. Treatment of arrhythmias during pregnancy: safety considerations. Drug Safety. 20:(1):Jan. 1999;85-94
10. Szekely P., Snaith L. Paroxysmal tachycardia in pregnancy. Br Heart J. 15:1953;195-198
11. Upshaw c. A study of maternal electrocardiograms recorded during labor and delivery. Am J Obstet Gynecol. 107:1970;17-27
12. Mendelsohn C.L. Disorders of the heartbeat during pregnancy. Am J Obstet Gynecol. 72:1956;1268-1301
13. Hong R.A., Bandari A.K. Cardiac arrhythmias and pregnancy. Elkayam U., Gleicher N. Cardiac problems in pregnancy: diagnosis and management of maternal and fetal disease. 2nd ed :1990;167-180 Alan R Liss, Inc, New York
14. Tawam M., Levine J., Mendelson M., et al. Effect of pregnancy on paroxysmal supraventricular tachycardia. Am J Cardiol. 72:1993;838-840
15. Sobotka P.A., Mayer J.H., Bauernfeind R.A., Kanakis C., Rosen K.M. Arrhythmias documented by 24 h continuous ambulatory electrocardiographic monitoring in young women without apparent heart disease. Am Heart J. 101:1981;753
16. Elkayam U., et al. Principles and practice of medical therapy in pregnancy. 2nd ed :1992;168 Appleton & Lange, Norwalk, Conn
17. Cardiac Electrophysiology: From Cell to Bedside Eds Zipes DP. 2nd edn
18. Reinecke H., Cirkel U., Kerber S., Kotthoff S., et al. Pregnancy in patients after Mustard procedure for transposition of the great arteries. A case report and review of the literature. Kardiol. 86:1997;945-956
19. Megerian G., Bell J.G., Huhta J.C., Bottalico J.N., Weiner S. Pregnancy outcome following Mustard procedure for transposition of the great arteries: a report of five cases and review of the literature. Obstet Gynecol. 83:(4):April 1994;512-516
20. Canobbio MM, Morris C, Graham TP Pregnancy following atrial repair for d-transposition of great arteries. (Abstr) Cardiology in the Young, 2001, 11(supplement)
21. Cohen M.I., Rhodes L.A. Sinus node dysfunction and atrial tachycardia after the Fontan procedure: the scope of the problem. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 1:1998;41-52
22. Balaji S., Johnson T.B., Sade R.M., Case C.L., Gillette P.C. Management of atrial flutter after the Fontan procedure. J Am Coll Cardiol. 23:(5):April 1994;1209-1215
23. Canobbio M.M., Mair D.D., van der Velde M., Koos B.J. Pregnancy outcomes after the Fontan repair. J Am Coll Cardiol. 28:(3):Sep. 1996;763-767
24. Pregnancy categories for prescription drugs. FDA Drug Bull 1982 Dec;12(3):24-25
25. American Academy of Pediatrics. The transfer of drugs and other chemicals into human milk. Pediatrics 2001;108: 776-789
26. Vaughn Williams E.M. Classification of antiarrhythmic drugs. Sandoe E., Flensted-Jensen E., Olsen K.H. Cardiac Arrhythmias. 1970;449-472 Astra, Sodertalje, Sweden
27. Brown C.E., Wendel G.D. Cardiac arrhythmias during pregnancy. Clin Obstet and Gynecol. 32:1989;89-102
28. Meyer J., Lackner J.E., Schochet S.S. Paroxysmal tachycardia in pregnancy. AM Heart J. 94:1931;1901-1904
29. Hill L.M., Malkasian G.D. The use of quinidine sulfate through out pregnancy. Obstet Gynecol. 54:1979;366-368
30. Wladimiroff J.W., Stewart A. Treatment of fetal cardiac arrhythmias. Br J Hosp Med. 34:1985;134-140
31. Cox J.L., Gardner M.J. Treatment of cardiac arrhythmias during pregnancy. Prog Cardiovasc Dis. 36:1993;137-178
32. Allen N.M., Page R.L. Procainamide administration during pregnancy. Clin Pharm. 12:1993;58-60
33. Page R.L. Treatment of arrhythmias during pregnancy. AM Heart J. 130:1995;871-876
34. Tadmore O.P., Keren A., Rosenak D., et al. The effect of disopyramide on uterine contractions during pregnancy. Am J Obstet Gynecol. 162:1990;482
35. Cox, Schnider S.M., et al. Choice of anesthesia for labor and delivery. Obstet Gynecol. 58:1981;S24-S34
36. Martin L.V., Jurand A. The absence of teratogenic effects of some analgesics use in anesthesia: additional evidence from a mouse model. Anaesthesia. 47:1992;473-476
37. Gregg A.R., Tomich P.G. Mexiletene use in pregnancy. J Perinatol. 8:1988;33-35
38. Timmis A.D., Jackson G., Holt D.W. Mexiletine for control of ventricular dysrhythmias during pregnancy. Lancet. II:1980;647-648
39. Lowes H.E., Ives T.J. Mexiletine use in pregnancy and lactation. Am J Obstet Gynecol. 157:1987;446-447
40. Rotmenech H.H., Elkayam U., Frichman W. Antiarrhythmic drug therapy during pregnancy. Ann Intern Med. 98:1983;487-497
41. Simpson J.M., Sharland G.K. Fetal tachycardias: management and outcome of 127 consecutive cases. Heart. 79:(6):June 1998;576-581
42. Ebenroth E.S., Cordes T.M., Darragh R.K. Second-line treatment of fetal supraventricular tachycardia using flecainide acetate. Pediatr Cardiol. 22:(6):Nov.-Dec. 2001;483-487
43. Fagih B., Sami M. Safety of antiarrhythmics during pregnancy: case report and review of the literature. Can J Cardiol. 15:(1):Jan. 1999;113-117
44. Villanova C., Muriago M., Nava F. Arrhythmogenic right ventricular dysplasia: pregnancy under flecainide treatment. G Ital Cardiol. 28:(6):June 1998;691-693
45. Oral beta-blockers for mild to moderate hypertension during pregnancy. Magee LA, Duley L. Cochrane Database Syst Rev 2000;(4):CD002863
46. Lip G.Y.H., Beevers M., Churchill D., et al. Effect of atenolol on birth weight. Am J Cardiol. 79:1997;1436-1438
47. Bartalena L., Bogazzi F., Braverman L.E., Martino E. Effects of amiodarone administration during pregnancy on neonatal thyroid function and subsequent neurodevelopment. J Endocrinol Invest. 24:(2):Feb. 2001;116-130
48. Widerhorn J., Bhandari A.K., Bughi S., Rahimtoola S.H., Elkayam U. Fetal and neonatal adverse effects profile of amiodarone treatment during pregnancy. Am Heart J. 122:(4 Pt 1):1991;1162-1166
49. Magee L.A., Nulman I., Rovet J.F., Koren G. Neurodevelopment after in utero amiodarone exposure. Neurotoxicol Teratol. 21:(3):May-June 1999;261-265
50. Magee L.A., Downar E., Sermer M., Boulton B.C., Allen L.C., Koren. Pregnancy outcome after gestational exposure to amiodarone in Canada. Am J Obstet Gynecol. 172:(4 Pt 1):April 1995;1307-1311
51. Babin J.P., Carre M., Martin C. Possible embryofetopathy caused by beta-blocker (sotalol) taken throughout the pregnancy. Pediatrie. 40:(2):March 1985;129-136
52. Skold A.C., Danielsson B.R. Developmental toxicity in the pregnant rabbit by the class III antiarrhythmic drug sotalol. Pharmacol Toxicol. 88:(1):Jan. 2001;34-39
53. Oudijk M.A., Michon M.M., Kleinman C.S., Kapusta L., Stoutenbeek P., Visser G.H., Meijboom E.J. Sotalol in the treatment of fetal dysrhythmias. Circulation. 101:(23):13 June 2000;2721-2726
54. Bryerly W.G., Hartman A., Foster D.E., Tannenbaum A.K. Verapamil in the treatment of maternal paroxysmal supraventricular tachycardia. Ann Emerg Med. 20:1991;552-554
55. Holbrook R.H., Gibson R.N., Voss E.M. Tocolytic and cardiovascular effects of the calcium antagonist diltiazem in the near-term pregnant rabbit. Am J Obstet Gynecol. 159:(3):Sept. 1988;591-595
56. Nelson Textbook of Pediatrics. Ed: Behrman, W.B. Saunders. p 483
57. Lamont R., van Eyck J. Obstet Gynecol. 97:(5 Pt 2):May 2001;840-847. Comment in Obstet Gynecol 2002 Mar, 99(3):518-9; discussion 519-20 Tocolysis with nifedipine or beta-adrenergic agonists: a meta-analysis.
58. Cox J.L., Gardner M.J. Treatment of cardiac arrhythmias during pregnancy. Prog Cardiovasc Dis. 36:1993;137-178
59. Jackson R.A., Teplin C.L., Drev E.A., Thomas L.I., Darney P.D. Digoxin to facilitate late second-trimester abortion: a randomized, masked, placebo-controlled trial. Obstet Gynecol. 97:(3):March 2001;471-476
60. Omar H.A., Rhodes L.A., Ramirez R., Arsich J., Einzig S. Alteration of human placental vascular tone by antiarrhythmic medications in vitro. J Cardiovasc Electrophysiol. 7:(12):Dec. 1996;1197-1203
61. Chakhtoura N., Angioli R., Yasin S. Prim. Care Update Ob Gyns. 5:(4):1 July 1998;154. Use of adenosine for pharmacological cardioversion of SVT in pregnancy
62. Dunn J.S., Brost B.C. Am J Emerg Med. 18:(2):March 2000;234-235. Fetal bradycardia after IV adenosine for maternal PSVT.
63. Yoneyama Y., Sawa R., et al. Regulation of plasma adenosine levels in normal pregnancy. Gynecol Obstet Invest. 53:(2):2002;71-74
64. Toppenberg K.S., Hill D.A., Miller D.P. Safety of radiographic imaging during pregnancy. Am Fam Physician. 59:1999;1813-1818
65. Timins J.K. Radiation during pregnancy. N J Med. 98:2001;29-33
66. Elkayam U., Gleicher N. Diagnostic approaches to maternal heart disease during pregnancy. Gleicher N., Elkayam U. Principles and practice of medical therapy in pregnancy. 2nd ed :1992;41-45 Appleton & Lange, Norwalk, Conn
67. Dominguez A., Iturralde P., Hermosillo A.G., Colin L., Kershenovich S., Garrido L.M. Successful radiofrequency ablation of an accessory pathway during pregnancy. Pacing Clin Electrophysiol. 22:(1 Pt 1):Jan. 1999;131-134
68. Israel C.W., Hugl B., Unterberg C., Lawo T., Kennis I., Hettrick D., et al. The AT500 verification study investigators. J Cardiovasc Electrophysiol. 12:(10):Oct. 2001;1121-1128. Pace-termination and pacing for prevention of atrial tachyarrhythmias: results from a multicenter study with an implantable device for atrial therapy
69. Ricci R., Santini M., Puglisi A., Azzolini P., Capucci A., Pignalberi C., et al. Impact of consistent atrial pacing algorithm on premature atrial complexes number and paroxysmal atrial fibrillation recurrences in brady-tachy syndrome: a randomized prospective cross over study. Interv Card Electrophysiol. 5:(1):March 2001;33-44
70. Lam C.T., Lau C.P., Leung S.k, Tse H.F., Lee K.L., Tang M.O., et al. Efficacy and tolerability of continuous overdrive atrial pacing in atrial fibrillation. Europace. 2:(4):2000;286-291
71. Piper J.M., Berkus M., Ridgeway L.F. III. Pregnancy complicated by chronic cardiomyopathy and an automatic implantable cardioverter defibrillator. Am J Obstet Gynecol. 167:1992;506-507
72. Isaacs J.D., Mulholland D.H., Hess L.W., Albert J.R., Martin R.W. Pregnancy in a woman with an automatic implantable cardioverter defibrillator: a case report. J Reprod Med. 36:(6):1993;487-488
73. Natale A., Davidson T., Geiger M.J., Newby K. Implantable cardiverter-debrillators and pregnancy: a safe combination. Circulation. 96:1997;2808-2812
74. Rosemond R.L. Cardioversion during pregnancy. J Am Med Assoc. 269:1993;3167
75. Finlay A.Y., Edmonds V. DC cardioversion in pregnancy. Br J Clin Pract. 33:1979;88-94
76. Klepper I. Cardioversion in late pregnancy. Anesthesia. 36:1981;611-616
77. Nanson J., Elcock D., Williams M., Deakin C.D. Do physiological changes in pregnancy change defibrillation energy requirements? Br J Anaesth. 87:(2):August 2001;237-239
78. Anbarasan C., Kumar V.S., Latchumanadhas K., Mullasari A.S. Successful thrombolysis of prosthetic mitral valve thrombosis in early pregnancy. J Heart Valve Dis. 10:(3):May 2001;383-385
79. Rinaldi J.P., Yassine M., Aboujaoude F., Belhakem H., Alsagheer S., Ben Ahmed F., et al. Successful thrombolysis on an aortic valve prosthesis by plasminogen tissue activator during pregnancy. Arch Mal Coeur Vaiss. 92:(4):Apr 1999;427-430
80. 2000 ACLS Guidelines. Part 8: Advanced Challenges in Resuscitation. Circulation. 2000;102:I-229
81. Campbell LA. Implications for pregnant patient. Am J Respir Crit Care Med 163:1051-1054
82. Lee R.V., Rodgers B.D., White L.M., et al. Cardiopulmonary resuscitation of pregnant women. Am J Med. 81:1986;311-318
83. American Heart Association. Special resuscitation situations. In: Cumin RU (Ed.), Advanced cardiac life support. Dallas, TX: American Heart Association; 1997
84. Gregoratos G., Cheitlin M.D., et al. ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 31:(5):April 1998;1175-1209